green
Positive treatment
2.9 score
Treatment trajectory · 1988 → 2026 · click a year to view as-of
1988
2007
2026
Top citers, strongest first. 3 distinct citers.
How cited ↗
discussed
Cited as authority (rule)
Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp
See, e.g., Abbott Labs., 471 F.3d at 1368 (“The general principle that a newly-discovered property of the prior art cannot support a patent on that same art is not avoided if the patentee explicitly claims that property.”); E.I. du Pont de Nemours & Co., 849 F.2d at 1436 (claimed copolymer defined in part by property parameters would not be new if property limitations were possessed by putative prior inventor’s products, even if prior inventor was unaware of that fact).
discussed
Cited as authority (rule)
FieldTurf USA, Inc. v. Sports Construction Group LLC
“Where a specification does not require a limitation, that limitation should not be read from the specification into the claims.” E.I du Pont de Nemours & Co. v. Phillips Petroleum Co., 849 F.2d 1480, 1488 (Fed.Cir.1988) (quoting Specialty Composites v. Cabot Corp., 845 F.2d 981, 987 (Fed.Cir.1988) (emphasis in original)).
discussed
Cited "see"
Lyden v. Howerton
See Hudson v. Secretary, 839 F.2d 1453 (11th Cir.), rehearing denied, 849 F.2d 1480 (11th Cir.), cert. granted, — U.S. -, 109 S.Ct. 527 , 102 L.Ed.2d 559 (1988); Reeves v. Bowen, 860 F.2d 1009 (11th Cir.1988).
Retrieving the full opinion text from the archive…
Save Our Dunes
v.
Pegues (Leigh)
v.
Pegues (Leigh)
87-7052.
Court of Appeals for the Eleventh Circuit.
May 24, 1988.
849 F.2d 1480
Published
Save Our Dunes
v.
Pegues (Leigh)
NOS. 86-7014, 87-7052
United States Court of Appeals,
Eleventh Circuit.
MAY 24, 1988
Appeal From: M.D.Ala., 834 F.2d 984
1
DENIALS OF REHEARING EN BANC.